Peripartum Depression Support Protocol
Primary Stack
Core supplements with strongest evidenceEssential for brain function; pregnancy depletes maternal DHA; supports mood regulation
Supporting Studies (1)
Deficiency linked to depression; safe in pregnancy at appropriate doses
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsSupports neurotransmitter synthesis; important during pregnancy
Supporting Studies (1)
Involved in serotonin synthesis; may help with mood
Supporting Studies (1)
Anemia common in pregnancy; iron deficiency linked to depression
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Peripartum depression includes depression occurring during pregnancy (prenatal/antenatal) and after delivery (postpartum). It affects about 10-20% of mothers and can impact both mother and baby.
SYMPTOMS:
RISK FACTORS:
CRITICAL: Peripartum depression requires professional treatment. This protocol is SUPPORTIVE ONLY.
MEDICAL TREATMENTS:
IMPORTANT:
* Omega-3s support brain health and may help mood.
* Vitamin D deficiency is common and linked to depression.
* Correct nutritional deficiencies (iron, folate, B vitamins).
Expected timeline: Supplements may take 4-8 weeks to show benefit. Professional treatment is essential for moderate-severe symptoms.
Clinical Perspective
Peripartum Depression: Major depressive episode during pregnancy or within 4 weeks postpartum (DSM-5). Prevalence ~10-20%. Risk factors: prior depression, lack of support, stressful events, sleep deprivation. Screen with Edinburgh Postnatal Depression Scale (EPDS).
CRITICAL: Untreated depression affects maternal-fetal bonding, child development. Treatment: psychotherapy (IPT, CBT) first-line for mild-moderate; antidepressants for moderate-severe. SSRIs generally safe in pregnancy/lactation. Brexanolone for severe postpartum. Supplements adjunctive: omega-3 has most evidence; vitamin D if deficient; correct anemia. Baby blues normal first 2 weeks; persistent symptoms need treatment.
* Omega-3 (B-grade): Brain/mood support. Meta-analysis: (PMID: 27840029). 2-3g EPA+DHA daily.
* Vitamin D (B-grade): Mood support. Systematic review: (PMID: 28750270). 2000-4000 IU daily.
* Folate/Methylfolate (C-grade): Neurotransmitter synthesis. Systematic review: (PMID: 27450775). 800-1000mcg daily.
* Vitamin B6 (C-grade): Serotonin synthesis. Review: (PMID: 27450775). 25-50mg daily.
* Iron (B-grade): If deficient. Review: (PMID: 28252380). Address anemia.
Assessment targets: EPDS score, symptom resolution, functional status, bonding.
Protocol notes: Screening: EPDS recommended; score >10 warrants further evaluation. SSRIs: sertraline, paroxetine commonly used; discuss risk/benefit. Breastfeeding: most SSRIs compatible; sertraline, paroxetine preferred. Brexanolone: IV infusion over 60h; for severe postpartum; new oral formulation (zuranolone) emerging. Psychotherapy: IPT specifically developed for perinatal; CBT also effective. Partner support: include partner in care; screen for partner depression. Sleep: critical factor; share nighttime duties if possible. Exercise: safe and beneficial during pregnancy; supports mood. Red flags: thoughts of harm to self/baby, psychosis - urgent psychiatric care. Prevention: omega-3 during pregnancy may prevent in high-risk women.